RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered bioprocess media, and ...

MineBio to distribute RoosterBio’s full platform of research-grade and CliniControl cGMP-grade MSC and exosome bioprocessing media in China: Frederick, Maryland Thursday, April ...

RoosterBio’s CliniControl portfolio includes cGMP MSC expansion media, exosome collection media, and bioreactor feeds.

Step-by-step guidance outlines the five core cGMP quality components, key FDA identity tests, and preparation for 2026 ...

Today’s biopharmaceutical innovators and contract development and manufacturing organizations (CDMOs) face no shortage of challenges in their current good manufacturing practices (cGMP) chemical ...

SAN FRANCISCO & COLUMBUS, Ohio--(BUSINESS WIRE)--Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions, and Forge Biologics, ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has entered into a development and ...

Thanks to the approval by the Italian Medicines Agency (AIFA), the Company increases its efficiency and is able to face the growing demand for its services. MILAN--(BUSINESS WIRE)--Dipharma Francis ...

Celltrion Inc. announced plans to acquire from Eli Lilly and Co. a Branchburg, N.J.-based biologics cGMP facility for $330 million up front, with plans to invest up to a total of ₩1.4 trillion (US$1 ...

The US Food and Drug Administration (FDA) has warned an oncology drug company for repeatedly overstating the efficacy of its drug in advertisements while failing to adequately disclose the associated ...